Suppr超能文献

摇头丸(MDMA)与预防MDMA神经毒性的药物联合使用,对大鼠体温产生不同影响。

Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.

作者信息

Malberg J E, Sabol K E, Seiden L S

机构信息

University of Chicago, Department of Pharmacological and Physiological Sciences, Illinois, USA.

出版信息

J Pharmacol Exp Ther. 1996 Jul;278(1):258-67.

PMID:8764359
Abstract

The substituted amphetamine 3,4-methylenedioxymethamphetamine (MDMA) has been shown to be neurotoxic to serotonin (5HT) terminals in the rat, and rat body temperature (TEMP) has been shown to affect this neurotoxicity. This study looked at the effect on CORE TEMP of three drugs that protect against MDMA neurotoxicity in the rat. Male Holtzmann rats were injected with a control saline (SAL) injection or with ketanserin (KET; 6 mg/kg), alpha-methyl-p-tyrosine (AMPT; 75 mg/kg) or fluoxetine (FLUOX; 10 mg/kg) before a 40-mg/kg MDMA or SAL injection. CORE TEMP was recorded throughout the study using a noninvasive peritoneally implanted temperature probe. Rats pretreated with KET had no change in CORE TEMP until MDMA was injected, at which time an immediate hypothermia was seen that continued for 180 minutes, with a peak low of 34.7 degrees C. Rats treated with AMPT had no change in CORE TEMP until the MDMA was injected, at which time an immediate hypothermia was seen that continued for 240 min., with a peak low of 34.3 degrees C. Two weeks later, brain regions were analyzed for 5-HT and 5-hydroxindole acetic acid levels. MDMA produced significant (P < .05) decreases in 5-HT and 5-hydroxindole acetic acid levels in the frontal cortex, somatosensory cortex, striatum and hippocampus, and pretreatment with KET or AMPT prevented these depletions. When rats were given the KET/MDMA or AMPT/MDMA drug injections and warmed to prevent hypothermia, the protection against neurotoxicity was removed, which indicated that the hypothermia mediated the protective effects of KET and AMPT. In comparison with the hypothermia seen with AMPT or KET pretreatment, pretreatment with FLUOX had no effect on CORE TEMP. The rats given the FLUOX/MDMA treatment did not have different CORE TEMPs than rats given SAL/MDMA. The FLUOX pretreatment protected against MDMA-induced 5-HT and 5-hydroxindole acetic acid depletions in the frontal cortex, somatosensory cortex, striatum and hippocampus. This study suggests that a decrease in CORE TEMP may be a mechanism of protection against MDMA neurotoxicity by some drugs but that there is also a mechanism of protection that is independent of a change in body temperature.

摘要

已证实,替代苯丙胺3,4-亚甲基二氧基甲基苯丙胺(摇头丸)对大鼠的5-羟色胺(5HT)终末具有神经毒性,且已证实大鼠体温(TEMP)会影响这种神经毒性。本研究观察了三种可预防大鼠摇头丸神经毒性的药物对核心体温(CORE TEMP)的影响。给雄性霍尔茨曼大鼠注射对照生理盐水(SAL),或在注射40mg/kg摇头丸或生理盐水之前,注射酮色林(KET;6mg/kg)、α-甲基对酪氨酸(AMPT;75mg/kg)或氟西汀(FLUOX;10mg/kg)。在整个研究过程中,使用非侵入性腹膜植入温度探头记录核心体温。用KET预处理的大鼠在注射摇头丸之前核心体温没有变化,此时立即出现体温过低,并持续180分钟,最低峰值为34.7摄氏度。用AMPT治疗的大鼠在注射摇头丸之前核心体温没有变化,此时立即出现体温过低,并持续240分钟,最低峰值为34.3摄氏度。两周后,分析脑区的5-羟色胺和5-羟吲哚乙酸水平。摇头丸使额叶皮质、体感皮质、纹状体和海马体中的5-羟色胺和5-羟吲哚乙酸水平显著降低(P<0.05),用KET或AMPT预处理可防止这些消耗。当给大鼠注射KET/摇头丸或AMPT/摇头丸药物并进行升温以防止体温过低时,对神经毒性的保护作用消失,这表明体温过低介导了KET和AMPT的保护作用。与AMPT或KET预处理时出现的体温过低相比,用FLUOX预处理对核心体温没有影响。接受FLUOX/摇头丸治疗的大鼠与接受SAL/摇头丸治疗的大鼠的核心体温没有差异。FLUOX预处理可防止摇头丸引起的额叶皮质、体感皮质、纹状体和海马体中5-羟色胺和5-羟吲哚乙酸的消耗。本研究表明,核心体温降低可能是某些药物预防摇头丸神经毒性的一种机制,但也存在一种与体温变化无关的保护机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验